Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema

Abstract

These results suggest that tolvaptan may provide high response rates when used early in the course of hepatic edema, or when both hepatic and renal functions are still retained, leading to an improved disease prognosis.